Advertisement

Efficacy of a Test-Retest Strategy in Residents and Health Care Personnel of a Nursing Home Facing a COVID-19 Outbreak

      Abstract

      Objective

      To assess the American Testing Guidance for Nursing Homes (NHs)—updated May 19, 2020—with a new COVID-19 case.

      Design

      Case investigation.

      Setting and Subjects

      All 79 residents and 34 health care personnel (HCP) of an NH.

      Methods

      Seven days after identification of a COVID-19 resident, all residents and HCP underwent real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) testing for SARS-CoV-2 with nasopharyngeal swabs. This was repeated weekly in all previously negative subjects until the testing identified no new cases, and in all positive subjects until the testing was negative. COVID-19 infection prevention and control (IPC) measures were implemented in all residents and HCP with positive testing or with COVID-19 symptoms. Standard IPC was also implemented in all HCP. Six weeks after initial testing, all residents underwent testing for enzyme-linked immunosorbent assay–based IgG antibodies directed against the SARS-CoV-2. Symptoms were serially recorded in residents and HCP.

      Results

      A total of 36 residents had a positive rRT-PCR at baseline and 2 at day 7. Six HCP had a positive rRT-PCR at baseline and 2 at day 7. No new COVID-19 cases were diagnosed later. Among the SARS-CoV-2–positive cases, 6 residents (16%) and 3 HCP (37%) were asymptomatic during the 14 days before testing. Twenty-five residents (92.3%) and all 8 HCP (100%) with a positive rRT-PCR developed IgG antibodies against SARS-CoV-2. Among the residents and HCP always having tested negative, 2 (5%) and 5 (11.5%), respectively, developed IgG antibodies against SARS-CoV-2. These 2 residents had typical COVID-19 symptoms before and after testing and 2/5 HCP were asymptomatic before and after testing.

      Conclusions and Implications

      This study shows the validity of the updated American Testing Guidance for Nursing Homes (NHs). It suggests implementing COVID-19 IPC in both residents and HCP with positive testing or COVID-19 symptoms and warns that asymptomatic HCP with repeated negative rRT-PCR testing can develop antibodies against SARS-CoV-2.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McMichael T.M.
        • Currie D.W.
        • Clark S.
        • et al.
        Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.
        N Engl J Med. 2020; 382: 2005-2011
        • Arons M.M.
        • Hatfield K.M.
        • Reddy S.C.
        • et al.
        Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility.
        N Engl J Med. 2020; 382: 2081-2090
        • Sethuraman N.
        • Jeremiah S.S.
        • Ryo A.
        Interpreting Diagnostic Tests for SARS-CoV-2.
        JAMA. 2020 May 6; ([Epub ahead of print])
        • Centers for Disease Control and Prevention
        Testing guidance for nursing homes. Interim testing guidance in response to suspected or confirmed COVID-19 in nursing home residents and healthcare personnel. Coronavirus Disease 2019 (COVID-19).
        (Available at:) (Accessed May 25, 2020)
        • Tuaillon E.
        • Bolloré K.
        • Pisoni A.
        • et al.
        Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
        J Infect. 2020 Jun 3; ([Epub ahead of print])
        • French Occitanie County Health Agency
        COVID-19 strategy for prevention in older subjects. [COVID19. Stratégie de Prévention des Personnes Agées. Agence Régionale de la Santé Occitanie (COVID-19)].
        (Available at:) (2020. Accessed May 25, 2020)